EYEOP1 developed by EyeTechCare is the first therapeutic ultrasound instrument equipped with a disposable miniaturised device for the treatment of refractory glaucoma.
Principle
EYEOP1 is a novel medical device developed by EyeTechCare, a system delivering non-invasive treatment for refractory glaucoma. This treatment can be administered on an outpatient basis and is performed under local anaesthaesia.
The patient simply lies down close to the command module and a disposable therapy device is placed on the globe of the eyeball.
The therapeutic phase of the procedure lasts only a minute and the procedure itself can be performed outside of the operating theatre in, for example, an examination room or medical consulting rooms.
EyeTechCare holds a portfolio of 5 patents on this new treatment system.
Command module
The EYEOP1 system contains a command module which enables the ophthalmologist to set parameters for the procedure and to control the procedure throughout the treatment period.
The module has a touch screen , a command pedal and visual and audible control systems, enabling completely safe treatment to be administered.
The command module is connected to the therapy device which is a sterile disposable part placed on the patient’s eyeball.
The command module is equipped with two types of interfaces allowing the clinician to interact with the machine:
a touch screen and its computer which allow the treatment parameters to be set
a command pedal to control the system.
The 2 essential components of the system are found within the command module:
the generator which delivers the required power to the piezoelectric transducers
the pressure reduction system which applies suction and therefore ensures fixation of the therapy device to the eyeball, guaranteeing that the quality of centring is maintained completely throughout the entire procedure.
EYEOP1 is entering the clinical study phase in human beings
